Studies in our laboratory recently extended this treatment period and showed that apocynin had no effect on oxidative stress at 3 days post-stroke, indicating that it is unlikely that Nox2-derived ROS are involved in lesion progression at this time [13]. The gene discussed is CYBB; the disease is stroke disorder.